Vienna Asset Management’s Novo Nordisk NVO Stock Holding History

Vienna Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,360	Closed	-$832K	–	68
2025 Q4	$832K	Buy	16,360 +4,845	+42%	+$248K	0.47%	40
2025 Q3	$639K	Buy	11,515 +6,215	+117%	+$364K	0.38%	37
2025 Q2	$366K	Buy	+5,300	New	+$361K	0.25%	42
2025 Q1	–	Sell	-5,022	Closed	-$432K	–	49
2024 Q4	$432K	Buy	5,022 +2,283	+83%	+$247K	0.29%	39
2024 Q3	$326K	Sell	2,739 -107	-4%	-$14.3K	0.24%	33
2024 Q2	$406K	Buy	+2,846	New	+$377K	0.34%	38
2024 Q1	–	Sell	-11,500	Closed	-$1.17M	–	52
2023 Q4	$1.17M	Buy	+11,500	New	+$1.14M	1.07%	23

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Vienna Asset Management's NVO Position: Q1 2026 in Review

Vienna Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 16,360 shares — an estimated $832K sold.

Vienna Asset Management first reported a position in NVO in Q4 2023 and held it in 7 quarters. The position peaked at $1.17M in Q4 2023. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Vienna Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Vienna Asset Management sold 16,360 Novo Nordisk shares in Q1 2026, an estimated $832K.
Vienna Asset Management first reported a position in Novo Nordisk in Q4 2023 and held it in 7 quarters.
Vienna Asset Management's Novo Nordisk position peaked at $1.17M in Q4 2023.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Vienna Asset Management's 13F filing for Q1 2026, filed 12 May 2026.